FDANonrulemakingFDA-2016-D-1233

Who commented on this docket

Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics; Draft Guidance for Stakeholders and Food and Drug Administration Staff; Availability

16 organizations filed 16 public comments on Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics; Draft Guidance for Stakeholders and Food and Drug Administration Staff; Availability, at the Food and Drug Administration. The comment window closed 3582d ago.

Organizations
16
Comments
16
RIN
Comment window
closed 3582d ago

Commenters (16)

  • American Association for Cancer Researchtrade assoc.
    1 filing · confidence 85%
  • American Association for Clinical Chemistrytrade assoc.
    1 filing · confidence 85%
  • American Cancer Society Cancer Action Networktrade assoc.
    1 filing · confidence 85%
  • American Clinical Laboratory Associationtrade assoc.
    1 filing · confidence 85%
  • American Medical Informatics Associationtrade assoc.
    1 filing · confidence 85%
  • American Society of Human Geneticstrade assoc.
    1 filing · confidence 85%
  • Association for Molecular Pathologytrade assoc.
    1 filing · confidence 85%
  • Foundation Medicinetrade assoc.
    1 filing · confidence 85%
  • Global Alliance for Genomics and Healthtrade assoc.
    1 filing · confidence 85%
  • National Society of Genetic Counselorstrade assoc.
    1 filing · confidence 85%
  • Personalized Medicine Coalitiontrade assoc.
    1 filing · confidence 85%
  • Pfizer Inc.unverified attribution
    1 filing · confidence 70%
  • The Coalition for 21st Century Medicinetrade assoc.
    1 filing · confidence 85%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.